Newera
Blog/Tutorials
TUTORIALSNov 4, 2026 · 1 min read

Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $410

By Benzinga Newsdesk

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $359 to $410.

Share this article

Keep reading.

TUTORIALS

Dow Rallies 2.9%, Oil Sinks 7% After Midterms: Stock Market Today

TUTORIALS

Intel Form4 Filing Shows CEO Lip-Bu Tan Purchases 150,000 Shares Of Intel Common Stock At Weighted Average Price Of $64.73/Share

TUTORIALS

Why Investors May Be Getting The Blue Wave Trade Wrong; Iran Remains The Wild Card

Trade what
you just read.

Apply the analysis on a live or demo account, same execution, no risk on demo.

Your seat at the market is ready.

Open your account in minutes, transparent pricing, fast withdrawals and support that answers.

Try a free demo

CFDs are complex instruments. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.